ion channel mAbs (argenx)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameion channel mAbs (argenx)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionSodium channel protein type X alpha subunit modulatorsSodium channel protein type IX alpha subunit modulatorsVoltage-gated potassium channel subunit Kv1.3 modulators

TargetsVoltage-gated potassium channel subunit Kv1.3Sodium channel protein type X alpha subunitSodium channel protein type IX alpha subunit

Therapy Area/IndicationsPainAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesArgenx Se

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesArgenx Se

Active IndicationsN/A

Inactive IndicationsPainAutoimmune Diseases

Other Information

ATC CodeN/A